PAR 1.69% 29.0¢ paradigm biopharmaceuticals limited..

The 3.8 quarters is misleading, it’s the equation of current...

  1. 2,149 Posts.
    lightbulb Created with Sketch. 802
    The 3.8 quarters is misleading, it’s the equation of current balance by the previous quarterly outflow of $6.8m.
    $26.2m by $6.8m = 3.8
    But as we know the $7.3m RnD refund is not included otherwise our runway would calculate as 1.8 quarters left of cash.
    Current quarter spend estimate is $7m - $10m, let’s go middle ground of $8.5m, that would leave $6.3m for each quarter of the remaining 2.8 quarters.

    Basically what I’m saying is those forward quarterly estimates can be taken with a gain of salt as they are not actual forward cash projections.

    I prefer to just go with the commentary, at the end of this quarter we should have $16m cash worst case if they keep to guidance.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.0¢
Change
-0.005(1.69%)
Mkt cap ! $101.4M
Open High Low Value Volume
29.5¢ 30.0¢ 29.0¢ $40.16K 137.1K

Buyers (Bids)

No. Vol. Price($)
5 66491 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 33118 1
View Market Depth
Last trade - 16.10pm 23/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.